One of the small-cap pharma stocks engaged in manufacturing and exporting PCR-based molecular diagnostic kits, PCR enzymes & PCR reagents, and agrochemical-based products. The stock has jumped by an intraday high of 19.65 percent after reporting September quarter results in 2024. The company’s revenue increased by 51.98 percent to Rs. 29.15 crore, and net profit … Continue reading Pharma stock jumps 19% after net profit increases by 86% YoY in Sept Qtr